共 50 条
- [21] Follicular and epidermal alterations in patients treated with ZD1839 (Iressa), an inhibitor of the epidermal growth factor receptorBRITISH JOURNAL OF DERMATOLOGY, 2002, 147 (03) : 598 - 601van Doorn, RKirtschig, GScheffer, EStoof, TJGiaccone, G
- [22] ZD1839 (Iressa), a novel epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, potently inhibits the growth of EGFR-positive cancer cell lines with or without erbB2 overexpressionINTERNATIONAL JOURNAL OF CANCER, 2001, 94 (06) : 774 - 782Anderson, NGAhmad, TChan, KDobson, RBundred, NJ
- [23] ZD1839 (℈Iressa℉), a specific oral epidermal growth factor receptor-tyrosine kinase inhibitor, potentiates radiotherapy in a human colorectal cancer xenograft modelBritish Journal of Cancer, 2002, 86 (7) : 1157 - 1161Williams K.J.Telfer B.A.Stratford I.J.Wedge S.R.
- [24] ZD1839 ('Iressa'), a specific oral epidermal growth factor receptor-tyrosine kinase inhibitor, potentiates radiotherapy in a human colorectal cancer xenograft modelBRITISH JOURNAL OF CANCER, 2002, 86 (07) : 1157 - 1161Williams, KJTelfer, BAStratford, IJWedge, SR
- [25] The effect of ZD1839 (Iressa™), an epidermal growth factor receptor tyrosine kinase inhibitor, in combination with cisplatin, on apoptosis in SCC-15 cellsCELL PROLIFERATION, 2005, 38 (02) : 77 - 86Al-Hazzaa, ABowen, IDRanderson, PBirchall, MA
- [26] Inhibition of growth factor production and angiogenesis in human cancer cell lines by ZD1839 (Iressa™), an EGFR-selective tyrosine kinase inhibitor.CLINICAL CANCER RESEARCH, 2000, 6 : 4542S - 4542SCiardiello, FCaputo, RPomatico, GDamiano, VBianco, RFontanini, GCuccato, SDe Placido, SBianco, ARTortora, G
- [27] ZD1839 (Iressa™) an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, inhibits proliferation in normal and preinvasive breast epithelia.CLINICAL CANCER RESEARCH, 1999, 5 : 3735S - 3735SChan, KCKnox, WFWoodburn, JRPotten, CSBundred, NJ
- [28] The EGFR-tyrosine kinase inhibitor Gefitinib ('iressa', ZD-1839) as potential therapeutic in bladder cancerJOURNAL OF UROLOGY, 2004, 171 (04): : 251 - 252Dominguez-Escrig, JLKelly, JDDavies, BR
- [29] Phase I data of ZD1839 - an oral epidermal growth factor receptor tyrosine kinase inhibitorANNALS OF ONCOLOGY, 1998, 9 : 109 - 109Kelly, HCLaight, AMorris, CQWoodburn, JRRichmond, GHP
- [30] Modulation of thymidine phosphorylase (TP) expression in breast cancer cell lines exposed to the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor ZD1839MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)Ait-Tihyaty, MariaRachid, ZakariaJean-Claude, Bertrand J.